Peer Reviewed
editorialoffice@confseries.net
+44 7897-071619
Follow Us:
Home
Instructions for Authors
Author Guidelines
Author Submission Policies
Publication Ethics and Policies
Editorial Panel
Editor-in-Chief
Editorial Board
Submit Manuscript
Aims and Scope
Articles in Process
Archive
Contact
Journal of Pharma and Drug Innovation
Frequency :
Annual (One issue per year)
Manuscript Guidelines
Journals
Membership
Editorial & Review Timeline
3 - 4 Days
Initial Quality Review
20 Days
Peer Evaluation Summary
30 - 45 Days
Complete Editorial Processing Time
Volume 1, Issue 1 (2026)
Research Article
|
J. Pharma Drug Innov. 2026 June 26; 1(1): 22 - 34
Design, Synthesis, and Antibacterial Evaluation of Novel Scaffold Pyrimidine Derivatives: A Structure-Activity Relationship Study
Santanu Kumar Hotta
1*
,
Krishna Chandra Panda
2
,
Asish Kumar Mohanty
1
,
Kanhu Charan Bisoyi
1
,
Pratibha Pradeep Pal
1
and
Smruti Suman Mahapatra
1
Abstract
html
PDF
Perspective
|
J. Pharma Drug Innov. 2026 June 08; 1(1): 20 - 21
Nanopharmaceuticals: Advances, Applications, and Future Perspectives in Drug Delivery and Therapeutics
Cherry Adams
*
html
PDF
Review Article
|
J. Pharma Drug Innov. 2026 June 04; 1(1): 9 - 19
Gut Dysbiosis: A Key Player in Metabolic health Management
Krishna Chandra Panda
*
,
B.V.V Ravi Kumar
*
,
Jammula Sruti
*
,
Digambar Bisoi
*
and
Laxmidhar Sahoo
*
Abstract
html
PDF
Editorial
|
J. Pharma Drug Innov. 2026 April 07; 1(1): 6 - 8
Nanostructured Systems and Therapeutic Innovation: Challenges and Opportunities
Eleonora Russo
*
html
PDF
Review Article
|
J. Pharma Drug Innov. 2026 March 04; 1(1): 1 - 5
Artificial Intelligence in Drug Discovery: Trends, Challenges, and Future Perspectives
Aura Rusu
*
Abstract
html
PDF
Abstract
html
PDF